Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “VOYAGER THERAPEUTICS, INC.”

31 pharma patents match "VOYAGER THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 31
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 31 pharmaceutical patents matching "VOYAGER THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

31 results for “VOYAGER THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 12419969

    AAV capsid variants and uses thereof

    VOYAGER THERAPEUTICS, INC. · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  2. US 12319929

    Compositions and methods for the treatment of Parkinson's disease

    VOYAGER THERAPEUTICS, INC. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  3. US 12305189

    Compositions and methods for delivery of AAV

    VOYAGER THERAPEUTICS, INC. · Granted May 20, 2025 · Expires May 15, 2045

    granted
  4. US 12296025

    AAV capsid variants and uses thereof

    VOYAGER THERAPEUTICS, INC. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  5. US 12291565

    Tau binding compounds

    VOYAGER THERAPEUTICS, INC. · Granted May 6, 2025 · Expires May 1, 2045

    granted
  6. US 12281321

    Frataxin expression constructs having engineered promoters and methods of use thereof

    VOYAGER THERAPEUTICS, INC. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  7. US 12252703

    Closed-ended linear duplex DNA for non-viral gene transfer

    VOYAGER THERAPEUTICS, INC. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  8. US 12146150

    Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery

    VOYAGER THERAPEUTICS, INC. · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  9. US 12129476

    Methods for measuring the potency of AADC viral vectors

    VOYAGER THERAPEUTICS, INC. · Granted Oct 29, 2024 · Expires Oct 24, 2044

    granted
  10. US 12123002

    Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

    VOYAGER THERAPEUTICS, INC. · Granted Oct 22, 2024 · Expires Oct 17, 2044

    granted
  11. US 12116589

    Treatment of amyotrophic lateral sclerosis (ALS)

    VOYAGER THERAPEUTICS, INC. · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted
  12. US 12084659

    Modulatory polynucleotides

    VOYAGER THERAPEUTICS, INC. · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  13. US 11975056

    AADC polynucleotides for the treatment of Parkinson's disease

    VOYAGER THERAPEUTICS, INC. · Granted May 7, 2024 · Expires May 2, 2044

    granted
  14. US 11951121

    Compositions and methods for treating Huntington's disease

    VOYAGER THERAPEUTICS, INC. · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  15. US 11931375

    Treatment of amyotrophic lateral sclerosis (ALS)

    VOYAGER THERAPEUTICS, INC. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  16. US 11859200

    AAV capsids with increased tropism to brain tissue

    VOYAGER THERAPEUTICS, INC. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  17. US 11759506

    AADC polynucleotides for the treatment of Parkinson's disease

    VOYAGER THERAPEUTICS, INC. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted
  18. US 11752181

    Compositions and methods of treating Huntington's disease

    VOYAGER THERAPEUTICS, INC. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  19. US 11603542

    Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

    VOYAGER THERAPEUTICS, INC. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  20. US 11542506

    Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

    VOYAGER THERAPEUTICS, INC. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  21. US 11512327

    Compositions and methods for delivery of AAV

    VOYAGER THERAPEUTICS, INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  22. US 11434502

    Treatment of amyotrophic lateral sclerosis (ALS)

    VOYAGER THERAPEUTICS, INC. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  23. US 11326182

    Compositions for the treatment of disease

    VOYAGER THERAPEUTICS, INC. · Granted May 10, 2022 · Expires May 5, 2042

    granted
  24. US 11299751

    Compositions for the treatment of disease

    VOYAGER THERAPEUTICS, INC. · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted